Navigation Links
Autism Study Finds Significant Benefit with Hyperbaric Treatment
Date:3/25/2009

MELBOURNE, Fla., March 25 /PRNewswire/ -- In a medical world that tells parents of autistic children to "accept" the condition of their child, a new study brings not only hope, but actual help, to these families. Lead physician and researcher, Daniel Rossignol, M.D., treats children with autism. Seeing his patients improve with hyperbaric oxygen treatment led him to conduct the first large scale, double-blind, controlled study to examine its effectiveness. And, the results of this study demonstrate positive improvements.

(Photo: http://www.newscom.com/cgi-bin/prnh/20090325/LA88558)

Hyperbaric therapy traditionally involves inhaling up to 100% oxygen at a pressure greater than 1 atmosphere (atm) in a pressurized chamber. In the first randomized, controlled, double-blind multicenter trial, published in BMC Pediatrics and entitled "Hyperbaric treatment for children with autism: a multicenter, randomized, double-blind, controlled trial." Dr. Rossignol and colleagues, from 6 centers in the USA, studied 62 children, aged 2-7 years, to assess the efficacy of hyperbaric treatment in children with autism.

The research trial concludes that children with autism who received hyperbaric treatment at 1.3 atmospheres and 24% oxygen for 40 hourly sessions had significant improvements in overall functioning, receptive language, social interaction, eye contact, and sensory/cognitive awareness compared to children who received slightly pressurized room air.

The children were randomly assigned to either 40 hours of hyperbaric treatment at 1.3 atm and 24% oxygen (treatment group) or slightly pressurized room air at 1.03 atm and 21% oxygen (non-treatment group). Clinical outcomes were evaluated by three different scales: the Clinical Global Impression (CGI) scale, the Aberrant Behavior Checklist (ABC), and the Autism Treatment Evaluation Checklist (ATEC).

Dr. Rossignol said, "In our study, we observed significant improvements in several core autistic behaviors with the use of hyperbaric therapy at 1.3 atm compared to children receiving near-placebo treatment. These findings confirm what we are seeing in clinical practice--that many children with autism may benefit with the use of this treatment."

Director of the International Hyperbarics Association, Shannon Kenitz, said, "With autism on the rise, it is promising to see a study that has been conducted with the high standards endorsed by the medical community. Having this scientifically controlled and analyzed study that shows the positive effects of hyperbarics is truly what this community has needed. The study not only presents the benefit of Hyperbaric Oxygen Therapy for children with autism, but also gives families the hope that so many other therapies have failed to do."

"The impact of this study on the autism community is significant. It brings validity to a successful intervention that needs to become part of mainstream medicine," commented Kyle Van Dyke, M.D., and Autism Specialist from Madison, Wisconsin.

According to Philip James, M.D., an expert in hyperbaric medicine out of the UK, this study is "An article of outstanding merit and interest in its field."

The growing concern regarding autism in this country is reinforced by the critically high ranking this study as earned by BMC Pediatrics. It is currently the most accessed article and projected to continue to climb in significance.

www.ihausa.org

Available Topic Expert(s): For information on the listed expert(s), click appropriate link.

Kyle VanDyke

https://profnet.prnewswire.com/Subscriber/ExpertProfile.aspx?ei=87122

Shannon Kenitz

https://profnet.prnewswire.com/Subscriber/ExpertProfile.aspx?ei=87051


'/>"/>
SOURCE International Hyperbarics Association, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Curemark Receives Investigational New Drug Clearance for CM-AT for Autism
2. Autism Website Relaunches to Offer Resources, Treatments and Hope for Families
3. NIH will use $60 million in Recovery Act funds to support strategic autism research
4. April is Autism Awareness Month
5. Heightened level of amygdala activity may cause social deficits in autism
6. Kids Brain Trust: A New Nonprofit Gives Parents Hope of Defeating Autism
7. Autism Speaks Celebrates Second Annual World Autism Awareness Day with an Array of International Events on April 2
8. Watch Me Learn Offers Schools a Teaching Solution for Children with Autism
9. Autism Support Network and the Israeli Society for Autistic Children Form International Alliance
10. Caldwell College to Host National Conference on Autism and Applied Behavior Analysis in April, Autism Awareness Month
11. UCI scientists to study brain region linked to autism, schizophrenia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2017)... CHICAGO, IL (PRWEB) , ... April 24, 2017 , ... Today, Bright Pink , ... cancer in young women, names a new CEO. , Bright Pink is proud to ... announced she would be moving to a new role as Chairman of the Board ...
(Date:4/24/2017)... Boca Raton, Florida (PRWEB) , ... April 24, ... ... that develops a variety of unique liquid food supplements, announced its popular products ... of nutritional products. , ALP Nutrition® prioritizes the use of premium natural ...
(Date:4/24/2017)... (PRWEB) , ... April 24, 2017 , ... ... (CDC), rising prescription opioid overdose deaths now claim the lives of 62 Americans ... civil case filings against drug manufacturers, distributors, pharmacies and prescribers by more than ...
(Date:4/24/2017)... ... 24, 2017 , ... As a former supermodel known for her timeless beauty, ... for single women is that she put all the words in her new book, ... insight, personal experiences and sparkling sense of humor have inspired her to write a ...
(Date:4/24/2017)... ... April 24, 2017 , ... “Reflections of God’s Work”: an enlightening collection ... Work” is the creation of published author, Jerri Broglin, a survivor of great loss ... believe this a great eye-opener for those searching for answers, as we are finding ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... EAST HANOVER, N.J. , April 19, 2017 ... study conducted by the National Heart, Lung, and ... Health (NIH) demonstrating that 58% of patients with ... at six months when treated with eltrombopag at ... treatment 1 . The study evaluated three sequential ...
(Date:4/18/2017)... April 18, 2017 Cogentix Medical, Inc. (NASDAQ: ... the Urology, Uro/Gyn and Gynecology markets with innovative and ... quarter ended March 31, 2017 after the market close ... Company will host a conference call and webcast to ... May 2, 2017 at 4:30 p.m. Eastern Time (3:30 ...
(Date:4/18/2017)... 2017  Astute Medical, Inc., developer of biomarkers for ... presented at the 2017 National Kidney Foundation (NKF) ... through April 22. Physicians will present data on two ... risk for acute kidney injury (AKI) during the management ... Elevated levels of TIMP-2 and IGFBP-7 have ...
Breaking Medicine Technology: